MedTrace Logo

Registry of Patients With Hematologic Disease and COVID-19 in Russia

NCT04422470 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 666

Last updated 2023-01-26

No results posted yet for this study

Summary

This is an observational prospective cohort study to evaluate the clinical course and outcomes of COVID-19 and the underlying disease in patients with hematologic disease (malignant or non-malignant).

Conditions

  • Coronavirus Infection and Hematologic Diseases

Interventions

OTHER

Non-interventional study

Non-interventional study

Sponsors & Collaborators

  • Foundation for Cancer Research Support (RakFond)

    collaborator UNKNOWN

  • Enrollme.ru, LLC

    collaborator NETWORK

  • National Research Center for Hematology, Russia

    lead NETWORK

Principal Investigators

  • Elena Parovichnikova · National Research Center for Hematology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-22
Primary Completion
2021-08-22
Completion
2022-01-18

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04422470 on ClinicalTrials.gov